“New England is attractive for world class academic talent, proximity to major healthcare providers and leading corporate partners,” says David Barone, NEIBC Life Sciences Chairperson
Waltham, MA (PRWEB) October 22, 2012
The 2012 New England-Israel Life Sciences Conference will be held on November 5 and 6, 2012 in Waltham, MA. This conference will feature over 50 distinguished speakers, representing many of the leading medical device, pharmaceutical, biotech, diagnostic, and healthcare IT companies in the area, major hospitals, research organizations, academia, investors, consulting firms and more, as well as a keynote address by Gary Gottlieb, M.D., President and Chief Executive Officer of Partners Healthcare. Other speakers include Robert Langer, Ph.D., Massachusetts Institute of Technology; Regina Herzlinger, Ph.D. and Noam Wasserman, Ph.D., Harvard Business School, Ruth Arnon, Ph.D., Weizmann Institute of Science and President, Israel Academy of Sciences and the Humanities; John Fish, Chairman and Chief Executive Officer of Suffolk Construction Company and Jami Rubin, Healthcare Research Group, Goldman Sachs.
"The Israeli and New England life sciences and healthcare communities consistently find and expand mutual interests that drive their growth and partnerships on many levels, not the least of which are technologic enterprise; 'out of the box' approaches to important medical challenges; and most importantly, a strong desire to improve the quality of services delivered by healthcare providers, and to enhance patients' lives in their own communities and beyond" said Dr. Gottlieb.
An independent 2010 study by Stax, Inc. assessed the contribution of Israeli entrepreneurship to the Massachusetts economy. The study found that the impact of Israeli companies operating in the State, and companies with Israeli founders or Israeli-licensed technologies in Massachusetts include $2.4 billion in direct revenue generated in Massachusetts, with nearly 6,000 Massachusetts-based employees working in these companies, mostly in knowledge-based positions.
“Israeli life sciences companies find New England operations attractive for a variety of reasons, not the least of which is the convergence of world class academic talent, proximity to major healthcare providers and leading edge corporate partners,” says David Barone, Chairman of the NEIBC Life Sciences Committee and Principal of Boston MedTech Advisors. "The Israeli and New England life sciences technology companies greatly appreciate the leadership and active participation of Governor Deval Patrick and his administration in helping to further expand Israel-New England life sciences collaborations."
A number of panels, including prominent members from life sciences companies, hospitals, research organizations and the financial industry, will discuss issues affecting the life sciences industry as it responds to the growing challenges encountered by healthcare providers. In addition, a number of Israeli companies will present innovative technologies promising to contribute to patient care.
Space is Limited. Register Now!
This conference is sponsored by the New England-Israel Business Council (NEIBC), an organization committed to expanding and fostering business and other collaboration opportunities between Israeli and U.S. firms.